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ABSTRACT
Objective: To review the effectiveness of non-pharmacological interventions in older adults with depression or
anxiety and comorbidities affecting functioning.
Design: Systematic review andmeta-analysis of randomized controlled trials, including searches of 10 databases
(inception-Jul 2017).
Setting: Home/community.
Participants: People aged 60 and over experiencing functional difﬁculties from physical or cognitive comorbid-
ities and have symptoms or a diagnosis of depression and/or anxiety.
Interventions: Non-pharmacological interventions targeted at depression/anxiety.
Measurements: We extracted outcome data on depressive symptoms, quality of life, functioning, and service
use. We used random effects meta-analysis to pool study data where possible. Two authors assessed the risk of
bias using the Cochrane Risk of Bias tool.
Results: We identiﬁed 14 eligible trials including 2099 randomized participants and two subgroup analyses.
Problem-solving therapy (PST) reduced short-term clinician-rated depressive symptoms (n = 5 trials, mean
difference in Hamilton Depression Rating Scale score −4.94 [95%CI −7.90 to −1.98]) but not remission, with
limited evidence for effects on functioning and quality of life. There was limited high-quality evidence for other
intervention types. Collaborative care did not appear to affect depressive symptoms, functioning, or quality of
life; and had mixed evidence for effects upon remission. No intervention consistently affected service use, but
trials were limited by small sample sizes and short follow-up periods. No anxiety interventions were identiﬁed.
Conclusion: PST may reduce depressive symptoms post-intervention in older people with depression and
functional impairments. Collaborative care appears to have few effects in this population. Future research needs
to assess cost-effectiveness, long-term outcomes, and anxiety interventions for this population.
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Introduction
Late-life mental health is becoming an increasingly
important issue. It is estimated that 37%–43% of
older adults have symptoms of anxiety or depression
(Braam et al., 2014; Rodda et al., 2011), while
9%–14% have a diagnosed anxiety or major depres-
sive disorder (Rodda et al., 2011; Wolitzky-Taylor
et al., 2010). Anxiety or depression in later life is
associated with an increased risk of cognitive decline,
functional decline, and increased use of healthcare
services (Meeks et al., 2011; Wolitzky-Taylor et al.,
2010). Frailer older adults, commonly experiencing
physical or cognitive comorbidities affecting function-
ing (i.e. difﬁculties carrying out activities of daily living
due to physical health conditions, in addition to dep-
ression), have a four-fold increase in the risk of clini-
cally signiﬁcant anxiety or depression (Ni Mhaolain
et al., 2012). Comorbid physical and mental health
disorders increases the risk of greater frailty, mortality,
and primary and secondary healthcare service use
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(Djernes et al., 2011; Vaughan et al., 2015). In an
ageing population, demand for mental health services
speciﬁc to later life is likely to increase.
There is an abundance of evidence assessing the
effectiveness of treatments for late-life depression.
However, frailer older adults represent an under-
studied subgroup of this population, and there
is evidence that physical illness, older age, and
impaired executive functioning can negatively impact
pharmacological and non-pharmacological treatment
outcomes (Tunvirachaisakul et al., 2017). Antidepres-
sants only appear to be effective when studied as a
class, rather than individual drug types, and when
reviews use an “older adult” threshold of 55+ years
rather than 65+ (Jonsson et al., 2016; Kok et al.,
2012). Antidepressant Randomized Controlled Trials
(RCTs) do not account for frailty or malnutrition and
the “older old (75+ years)” populations are under-
represented (Benraad et al., 2016), despite greater
concerns about falls and polypharmacy in these po-
pulations. Collaborative care interventions and home
care interventions have some evidence of effectiveness
for depression, but the evidence base is very limited
(Dham et al., 2017; Simning and Simons, 2017).
Exercise interventions for depression have not been
found to be effective in those with physical comorbid-
ities (Schuch et al., 2016). Additionally, many older
adults state a preference for psychological interven-
tions (Gum et al., 2006; Mohlman, 2011).
However, secondary care services (e.g. community
psychiatric services) focus mainly on severe mental
illness, while center-based and intensive approaches
may be unsuited to community-dwelling older adults
with limited mobility and frailty. Cognitive beha-
vioural therapy (CBT) shows smaller effect sizes for
older rather than younger adults and has mostly been
evaluated in samples with a mean age of 60–70 years
old in people who are otherwise healthy (Gould et al.
2012a; 2012b). Existing psychological therapies
offered in community settings may not fully account
for issues such as increasing dependency, social isola-
tion, reduced functional abilities and cognitive decline
that are key for older people. However, some non-
pharmacological therapies such as problem-solving
therapy have shown promise in reducing disability,
in addition to depression, in older adults with major
depressive disorder and may offer promise for further
research (Kirkham et al., 2016). Although some re-
views have looked at frailer subgroup analyses of older
adults (Jonsson et al., 2016), these have studied psy-
chological therapies alone and documented “frailty
indicators,” rather than clearly deﬁning an impaired
population.
Consequently, the only review of this subpopula-
tion with impairments as its main focus appears
to have been carried out two decades previously
(Landreville andGervais, 1997).We, therefore, aimed
to review the effectiveness of non-pharmacological
interventions to reduce depression and anxiety in
older adults with comorbidities affecting functioning.
Methods
We systematically reviewed Randomized Con-
trolled Trials (RCTs) (Prospero registration
CRD42017068441).
Search strategy and inclusion criteria
We developed a comprehensive search strategy (see
AppendixA1) with terms based on age, impairments,
depression/anxiety, and study type. We searched the
following databases (inception-July 2017): MED-
LINE, MEDLINE in Process & Other Non-Indexed
Citations, EMBASE, AMED,Web of Science: Social
ScienceCitation Index,CochraneCentral Register of
Controlled Trials and NHS Health Economic Eval-
uation Database, PsycINFO, Cumulative Index to
Nursing and Allied Health Literature, Sociological
Abstracts, Social Care Online, and Applied Social
Sciences Index and Abstracts.
We performed additional searches of clinical-
trials.gov, UK Clinical Trials Gateway, and World
Health Organization International Clinical Trials
Registry Platform (inception-Sep 2017) to identify
ongoing studies. We screened the reference lists of
included studies/relevant systematic reviews and
used forward citation tracking of all included stud-
ies.We used author searches to follow up conference
abstracts, trials register entries, and protocols where
available and necessary.
Our inclusion criteria were as follows:
• Participants: Older adults (aged 60+ years); func-
tional difﬁculties [including difﬁculties in activities
of daily living (ADLs) or instrumental ADLs
(IADLs), housebound, frail, low functioning scores
on a validated scale, recipient of relevant support
services (e.g. social care services)]; symptoms/diag-
nosis of depression and/or anxiety
• Interventions: Home- or community-based interven-
tions delivered by any health, social, lay, or voluntary
provider; single or multicomponent intervention
aimed primarily at addressing depression or anxiety
• Comparator: Any
• Outcomes: Depressive and anxiety symptoms using
validated questionnaires, other depression or anxiety
outcomes (e.g. recovery), well-being, quality of life,
functioning, service use
• Study type: Parallel-group, cluster, or crossover ran-
domized controlled trials, economic evaluations
of RCTs
We lowered our original age inclusion criterion
from 75+ to 60+ years, as this allowed inclusion of
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a number of additional relevant studies of function-
ally impaired older adults with mean ages 60–75.
We excluded interventions targeted at caregivers
or targeted at speciﬁc health conditions (e.g. demen-
tia, arthritis) in order to be more applicable to the
wider frailer population, such as people described
as generically “at risk” or “multimorbid” (unless
there were documented associated difﬁculties in
functioning); care-home interventions (recently
reviewed by Simning and Simons [2017]); studies
in which participants were not experiencing at least
mild depression/anxiety; inpatient interventions;
medication-only interventions (interventions con-
taining a medication component were included);
interventions focused primarily on another issue
(e.g. frailty, falls prevention) in which depression/
anxiety is a secondary target as it would be difﬁcult to
be sure of the effective components; reviews, quali-
tative studies, quasi-experimental, and uncontrolled
studies.
RF screened titles and abstracts, and YB inde-
pendently checked 10% of these. We took an
inclusive approach and screened the full texts of
all studies assessing interventions in samples of dep-
ressed or anxious older adults, as we anticipated that
difﬁculties in functioning may not be clearly re-
ported in the abstract. RF and YB independently
screened 10% of the full texts to ensure consis-
tency in applying the inclusion criteria, with dis-
agreements resolved through discussion, then each
screened 50% of the remaining full texts. Dual
review was undertaken for a further 7% of studies
where there was uncertainty, with input from KW
where needed. We contacted ﬁve authors for addi-
tional data to further inform about the inclusion
criteria, and three replied. We sought further data
regarding ten included studies from nine authors
and eight replied, six of whom were able to provide
further data.
Data extraction and quality assessment
We extracted data on participants, study type, inter-
vention description (according to the TIDIER check-
list [Hoffmann et al., 2014]), outcomes assessed, and
main ﬁndings. If a study had multiple publications,
we considered the main results paper as the primary
paper and included information from related papers
(e.g. protocols) where relevant. RF and YB indepen-
dently assessed risk of bias using the Cochrane Risk
of Bias tool (Higgins et al., 2011) and resolved dis-
agreements through discussion. Overall ratings were
judged on the least score counts; however, as non-
pharmacological therapies are often compared to
usual care and a placebo control is not always des-
irable or practical, we did not include participant
blinding in the overall trial rating. Within “other
bias,” we assessed whether studies documented or
controlled for use of antidepressants. Risk of bias
ratings informed our narrative synthesis.We intended
to assess publication bias using funnel plots but had
insufﬁcient data for this (Sterne et al., 2011).
Synthesis
We grouped studies according to intervention type:
problem-solving therapy, other psychological thera-
pies, and collaborative care (deﬁned as complex
interventions involving amulti-professional approach
to care, a structured management plan, scheduled
follow-ups, and enhanced interprofessional commu-
nication [Archer et al., 2012]). We conducted meta-
analysis of similar outcomes post-intervention, the
most relevant, andwidely available timepoint (follow-
up timepoint meta-analysis was precluded by differ-
ing outcome types and timepoints). Self-reported
and clinician-rated outcomes were not combined as
these produced different effect estimates in a previous
meta-analysis (Cuijpers et al., 2010). We summa-
rized effects for continuous data using mean differ-
ence (MD) or standardized mean difference (SMD),
where appropriate, withweighting by inverse variance
(Higgins and Green, 2011). For dichotomous data,
we combined effects using odds ratios, weighted by
the Mantel-Haenszel method (Higgins and Green,
2011). All analyses used a random effects model as
we anticipated high clinical heterogeneity, quantiﬁed
using the I2 statistic. Similar interventions within a
single trial were aggregated into one intervention
group for meta-analysis using Higgins and Green’s
(2011) formulae. Where necessary, we used p values
and test statistics to compute SDs, standardized
mean difference, and 95% conﬁdence intervals, then
we combined studies using the generic inverse vari-
ance method (Higgins and Green, 2011).
RF performed meta-analysis using Revman 5.3
(The Nordic Cochrane Centre, The Cochrane Col-
laboration 2014). YB checked all data used in meta-
analysis with the original papers or the authors’
communications and independently veriﬁed calcula-
tions (e.g. calculation of standard deviations from
p values). We narratively summarized all other out-
comes, including longer term follow-up timepoints.
Results
We identiﬁed 7708 unique references and screened
698 full texts (see Figure 1). Full texts were largely
excluded due to their not targeting depression/
anxiety (in participants or intervention [n = 181]),
study type (n = 164), or not targeting an impaired
older population (n = 154). We found ﬁve relevant
ongoing trials as protocols, or trial register entries,
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which had not previously been located (ﬁndings not
currently reported, summarized in Appendix A3).
Description of included studies
We included 14 trials with a total of n = 2099
randomized participants, comprising 11 RCTs
(Alexopoulos et al., 2016; Banerjee et al., 1996;
Choi et al., 2014; Ciechanowski et al., 2004; Ell
et al., 2007; Enguidanos et al., 2005; Gellis et al.,
2008; Kiosses et al., 2010; 2015; Nyunt 2010;
Serrano et al., 2004), one cluster RCT (Bruce et al.,
2015), one pilot RCT (Gellis et al., 2007), and
one RCT with a non-concurrent control group
(Llewellyn-Jones et al., 1999) (see Appendix A2
for a detailed summary of study characteristics). We
also included twoRCTsubgroup analyses (Blanchard
et al., 1995; Landreville andBissonnette, 1997) (one n
not reported, one n = 23 randomized). Most studies
were carried out in the US (n = 10), with two UK
studies (Banerjee et al., 1996; Blanchard et al., 1995),
and one each in Australia (Llewellyn-Jones et al.,
1999), Singapore (Nyunt 2010), Spain (Serrano et al.,
2004), and Canada (Landreville and Bissonnette,
1997). Sample sizes varied from 23 to 311.
Participant mean ages ranged from 64.8 to 84.9
years, with higher proportions of women in all trials
(range from 69.6% to 87.5%).Many studies captured
a diverse population, including substantial propor-
tions of ethnicminorities in studies reporting this data
(see Table 1). Four studies focused on or included a
considerable proportion of those with low incomes
(Alexopoulos et al., 2016; Bruce et al., 2015; Choi
et al., 2014; Landreville and Bissonnette, 1997) and a
range of educational levels were reported.Many stud-
ies used a screening instrument to deﬁne depression
criteria, with or without the Structured Clinical
Interview for DSM-IV (SCID-IV) (see Table 1).
The majority of studies excluded people below a
certain cognition threshold (n = 8) or those with
dementia (n = 3) (see Table 1). Consequently, many
studies, even if using a lower cognition threshold,
reported mean baseline cognition scores within a
Figure 1. Flow diagram of studies throughout the review.
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living
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Control Chinese 85.7%
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s of use, available at
normal range (i.e. Mini-Mental State Examination
(MMSE) scores between 26.8 and 29.3 across stud-
ies (Alexopoulos et al., 2016; Bruce et al., 2015;
Llewellyn-Jones et al., 1999), 1.58 on the Short
Portable Mental Status Questionnaire (Enguidanos
et al., 2005), and 5.5 on the 6-item MMSE [Ciecha-
nowski et al., 2004]). Only two studies included
people with greater cognitive impairment (Kiosses
et al., 2015) or executive dysfunction (Kiosses
et al., 2010) resulting in a wider range of cognition
scores, but still normal mean cognitive function in
Kiosses et al (2010). Two studies did not report any
cognition data (Banerjee et al., 1996; Blanchard et al.,
1995).
Risk of bias in included studies
Overall, most studies were at an unclear risk of bias
(see Figure 2), largely due to limited reporting of
random sequence generation (n = 8), allocation con-
cealment (n = 13), and lack of an online or published
protocol to assess selective reporting (n= 11). Studies
were most commonly at a low risk of bias for out-
come assessment (n = 12), incomplete outcome data
(n = 10), and reporting or controlling for antidepres-
sant use (other bias, n = 9). Studies were most
commonly at a high risk of bias for participant blind-
ing (n = 7), although this was expected as blinding
participants can be difﬁcult in trials of complex inter-
ventions and so these ratings were not included in the
overall score. Individual risk of bias ratings are dis-
cussed throughout the synthesis for each outcome.
Modiﬁed problem-solving therapy (n= 7 trials,
including n = 688 randomized participants)
Problem-solving therapy (PST) aims to systemati-
cally identify and address daily life problems to
reduce depression and improve future coping skills
(Ciechanowski et al., 2004) through standard steps
including: identifying problems, establishing achiev-
able goals, brainstorming solutions, using decision-
making guidelines, evaluating and contrasting
solutions, developing action plans, and evaluating
outcomes. PSTwas modiﬁed in some studies to suit
a more impaired population:
• Integration into existing home care services, with six
sessions to ﬁt home care’s fast pace and limited
resources and individuals’ frailty (Gellis et al., 2007;
2008)
• Emphasizing social activation, increasing outdoor
interactions, and developing an exercise program
(Ciechanowski et al., 2004)
• Problem Adaptation Therapy with environmental
adaptations to circumvent behavioral and/or func-
tional limitations and involving willing/available
caregivers over 12 weeks (Kiosses et al., 2010;
2015)
• Delivery over videoconferencing software (tele-
PST) to enable home-based therapy (Choi et al.,
2014)
• Increasing pleasant events (Choi et al., 2014;
Ciechanowski et al., 2004; Gellis et al., 2007; 2008;
Kiosses et al., 2010)
PST was most commonly delivered by social
workers (usually Masters-level) (Alexopoulos et al.,
2016; Choi et al., 2014; Ciechanowski et al., 2004;
Figure 2. Risk of bias in included studies (NB selective reporting
judgment refers to depressive symptoms and is highlighted where
different for other outcomes in the text).
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Gellis et al., 2007; Kiosses et al., 2010), registered
nurses (Ciechanowski et al., 2004) or clinical
psychologists, and clinical doctorate candidates
(Kiosses et al., 2015). All delivered PST face-
to-face at participants’ homes over 6–12 sessions,
apart from one trial comparing delivery over Skype
to face-to-face and to-care calls (Choi et al., 2014)
(collapsed to a single PST group for meta-analysis
as per Higgins and Green [2011]). Other trial com-
parators included usual care (Ciechanowski et al.,
2004), enhanced usual care (e.g. with basic educa-
tion) (Gellis et al., 2007; 2008) or attention controls
(e.g. supportive therapy) (Kiosses et al., 2010; 2015).
One compared case management plus PST to case
management alone (Alexopoulos et al., 2016).
DEPRESSIVE SYMPTOMS
Modiﬁed PST signiﬁcantly reduced clinician-
rated Hamilton Depression Rating Scale (HAM-D)
scores post-intervention (see Figure 3[a], n = 5, MD
−4.94 [95% CI −7.90 to −1.98], p = 0.001). Two
further studies found signiﬁcantly lower scores on
other measures, including the Montgomery–Åsberg
Depression Rating Scale (MADRS), compared
to supportive therapy (Kiosses et al., 2015) and 20-
item Hopkins Symptom Checklist Depression Scale
(HCSL-20) compared to usual care (Ciechanowski
et al., 2004). Reduced depressive symptoms were
maintained 6–12 months from baseline in studies
assessing this outcome (Alexopoulos et al., 2016;
Choi et al., 2014; Ciechanowski et al., 2004; Gellis
et al., 2008). All studies were at an overall unclear risk
of bias (with some low-risk domains), apart from
Choi et al. (2014), who used non-blinded outcome
assessors.However, PSTdid not signiﬁcantly increase
the post-intervention clinician-rated odds of response
(≥50% symptom reduction from baseline, OR 3.24
[95% CI 0.52 to 20.27], Figure 3[b]) or remission
(OR 2.62 [95%CI 0.57 to 12.16], Figure 3[c]) using
the HAM-D (Alexopoulos et al., 2016), HSCL-20
(Ciechanowski et al., 2004), and MADRS (Kiosses
et al., 2015). Similarly, no effects were found 12weeks
post-intervention (Alexopoulos et al., 2016) or at the
36-week (Choi et al., 2014) or 12-month follow-up
(Ciechanowski et al., 2004). Kiosses et al. (2015) did
not assess longer term outcomes.
We could not meta-analyze self-reported depre-
ssive symptoms, as two papers reported identical
mean and SD 15-item Geriatric Depression Scale
(GDS-15) scores at all timepoints, suggesting a re-
porting error (Gellis et al., 2007; 2008). These ﬁgures
did however, indicate signiﬁcantly lower symptoms
at post-intervention, 3 months, and 6 months (Gellis
et al., 2007; 2008). One also found signiﬁcantly lower
Beck Depression Inventory scores post-intervention
(PST vs. usual care, 10.20 vs 27.4, p < 0.001),
maintained at 6 months (Gellis et al., 2007).
FUNCTIONING AND DISABILITY
PST did not signiﬁcantly reduce self-reported
disability post-intervention (Figure 3[d], n = 4,
SMD −1.35 [95% CI −2.96 to 0.25], p = 0.10)
when assessed using the World Health Organization
Disability Assessment Schedule and the Sheehan
Disability Scale.Within one study, signiﬁcant effects
upon disability were maintained at 24 weeks for
tele-PST and face-to-face PST and at 36 weeks for
tele-PST (Choi et al., 2014). Another study, simi-
larly to post-intervention, found no effects at the
12-week follow-up (Alexopoulos et al., 2016).
QUALITY OF LIFE
Evidence about the impact of PSTupon the quality
of life wasmixed across two studies using theQuality
of Life Inventory. Meta-analysis was not undertaken
as the SDs (but not means) reported were identical
in both papers at all timepoints (Gellis et al., 2007;
2008), suggesting a potential reporting error. Sig-
niﬁcantly higher quality of life was found post-
intervention and at 3 and 6 months in Gellis et al.
(2007) but no effects were found in Gellis et al.
(2008). Within Ciechanowski et al. (2004) there
were improvements in emotional and functional
but not social or physical well-being over 12 months
on the Functional Assessment of Cancer Therapy
Scale: General.
SERVICE USE AND COSTS
None of the three studies reporting service use
found PST to signiﬁcantly affect primary, second-
ary, or home care service use over the treatment
period or longer follow up, although this was con-
sidered beneﬁcial where PST was delivered as part
of home care (Ciechanowski et al., 2004;Gellis et al.,
2007; 2008). One study reported intervention costs
($630 per patient) (Ciechanowski et al., 2004), and
two noted that social work home visits were reim-
bursable by Medicare (Gellis et al., 2007; 2008).
No other studies reported this data.
Collaborative care interventions (n = 7 studies
including n = 1351 participants)
Seven studies evaluated collaborative care interven-
tions, provided in the community or in care services
(components listed in Table 2). Key intervention
providers were usually nurses (Blanchard et al.,
1995; Bruce et al., 2015; Ell et al., 2007; Nyunt
2010), but could include social workers, psycholo-
gists (Ell et al., 2007), or medical staff (Banerjee
et al., 1996).
Baseline depressive symptoms levels were
mainly mixed (Blanchard et al., 1995; Bruce et al.,
2015; Ell et al., 2007; Enguidanos et al., 2005),
with two studies focusing on major depression
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(Banerjee et al., 1996; Llewellyn-Jones et al., 1999)
and one on minor depression (Nyunt 2010).
Comparators included “routine care” (further de-
tails not reported) (Llewellyn-Jones et al., 1999); GP
management with or without notiﬁcation of depres-
sion severity (Banerjee et al., 1996; Blanchard et al.,
1995; Ell et al., 2007; Nyunt 2010); usual geriatric
case management with care plan (Enguidanos et al.,
2005); and usual care enhanced by screening, noti-
fying GPs (Ell et al., 2007), or following agency
procedures (Bruce et al., 2015) if the patient did
not improve.
Potential meta-analysis for collaborative care in-
terventions relied mainly on data from an unpub-
lished thesis, Nyunt (2010), whose analysis was at
high risk of bias as they did not use an intention-
to-treat analysis. We, therefore, only undertook
meta-analysis where higher quality data were avail-
able (self-reported depressive symptoms).
EFFECTS UPON DEPRESSIVE SYMPTOMS (N = 7)
There were mixed effects on continuous depressive
symptom scores. Two large studies found no effects
on clinician-rated HAM-D scores post-intervention
Figure 3. Forest plots of meta-analyses: (a) meta-analysis of the effectiveness of problem-solving therapy upon clinician-rated depressive
symptoms; (b) meta-analysis of the effectiveness of problem-solving therapy upon response (≥50% reduction in symptoms from baseline);
(c) meta-analysis of the effectiveness of problem-solving therapy upon remission (not depressed according to threshold); (d) meta-analysis
of the effectiveness of problem-solving therapy upon self-reported disability; and (e) meta-analysis of the effects of collaborative care upon
self-reported depressive symptoms.
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or at 12 months (Bruce et al., 2015; Nyunt 2010).
A subgroup with major depression and one smaller
study (n = 69) found signiﬁcant reductions in
depressive symptoms (Banerjee et al., 1996; Bruce
et al., 2015), while Blanchard et al.’s (1995) sub-
group analysis found greater symptom improve-
ments in those with physical capacity than those
without, although this did not interact with the
treatment group. There were similarly no effects
upon post-intervention self-reported depressive
symptoms (n = 2, SMD −0.09 [95%CI −0.29 to
0.12], p = 0.41, Figure 3[e]). A further unpublished
study (at high risk of bias due to higher intervention
arm dropout rates) found no differences in 9-item
Patient Health Questionnaire (PHQ-9) scores post-
intervention or at 12 months (Enguidanos et al.,
2005). Nyunt (2010) (at high risk of bias) found
some differences in GDS and BDI scores post-
intervention but not at 12 months.
Odds of depression remission were mixed.
Banerjee et al. (1996) found signiﬁcantly higher
odds of clinician-rated remission usingGeriatricMen-
tal State AGECAT categories, while Nyunt (2010)
found no differences in remission using HAM-D at
any timepoint. Odds of self-reported remission was
signiﬁcantly higher using the GDS-15 (Nyunt
2010) with signiﬁcant positive movement into “less
depressed” categories using the GDS-30 cutoffs
(Llewellyn-Jones et al., 1999); but not using the
BDI (Nyunt 2010) or in the odds of response using
the PHQ-9 at 4, 8, or 12 months (Ell et al., 2007).
FUNCTIONING (N = 2)
There was no evidence that collaborative care affected
12-item Short Form (SF-12) physical functioning
subscale scores, Mahoney and Barthel Activities of
Daily Living (ADL) scores, Lawton Instrumental
Activities of Daily Living (IADL) scores (Nyunt
2010), or SF-20 scores (Ell et al., 2007) at any time-
point up to 12 months.
QUALITY OF LIFE (N = 2)
Mental functioning scores (SF-12) were signiﬁ-
cantly higher post-intervention in the collaborative
care group compared to usual care but not at 12
months in Nyunt (2010), and Ell et al. (2007) found
no differences in odds of an improvement in mental,
social, or role functioning scores.
SERVICE USE AND COSTS (N = 5)
One study found signiﬁcant effects for collaborative
care on the number of days in hospital (3.59 vs.
6.31, p = 0.04, unpublished data supplied by
authors) (Enguidanos et al., 2005). However, one
large cluster trial found no signiﬁcant reductions in
risk of 30- or 60-day hospitalization from home
health services (except when including service-level
data from all people in all clusters, rather than those
agreeing to full-study participation) (Bruce et al.,
2016). Others similarly found no differences in the
12-month odds of hospitalization (meta-analysis
not possible due to insufﬁcient data) (Ell et al.,
2007; Nyunt 2010), home care visits (Ell et al.,
2007; Enguidanos et al., 2005), primary care or
physician visits (Enguidanos et al., 2005; Nyunt
2010), home care readmissions (Ell et al., 2007),
moves to long-term care (Enguidanos et al., 2005),
or emergency department visits (Ell et al., 2007;
Enguidanos et al., 2005; Llewellyn-Jones et al.,
1999). Only Enguidanos et al. (2005) calculated
healthcare costs (unpublished), which were signiﬁ-
cantly lower at four months ($3295 vs. $5417,
p = 0.04) and 12 months ($8403 vs. $11,242,
p = 0.05). Banerjee et al. (1996) reported extra
costs of a part time doctor as a depression case
manager but did not cost this.
OTHER PSYCHOLOGICAL THERAPIES
The evidence base available for other psychological
therapies in this population consisted of small single
studies at an unclear risk of bias. Four sessions of life
review therapy that focused on different life periods
had signiﬁcant post-intervention effects on self-
reported depressive symptoms (20-item Center for
Epidemiological Studies—Depression Scale) and
life satisfaction (Life Satisfaction Index A), com-
pared to social visits in 50 social care services clients
(Serrano et al., 2004). Bibliotherapy (i.e. reading a
CBT-based book Feeling Good over 4 weeks) reduced
depressive symptoms in two out of three scales
(BDI, GDS-30, Inventory to Diagnose Depression)
compared to weekly supportive phone calls in
a subgroup analysis of 23 people with disability
in at ≥1 ADL, IADL or mobility, with no effect
upon functioning (Landreville and Bissonnette,
1997). Neither study reported service use or cost
data.
Discussion
Within this review, we included 14 RCTs including
2099 randomized individuals, plus two subgroup
analyses, primarily assessing modiﬁed problem-
solving therapy (n = 7) and collaborative care inter-
ventions (n = 7). For older adults with depression
and physical comorbidities affecting functioning, we
found that home-based PST signiﬁcantly reduced
depressive symptoms, but did not affect remission,
functioning, or service use, and showed mixed
effects on quality of life. The evidence for collabo-
rative care was heterogeneous, with no effects on
depressive symptoms in meta-analysis and narrative
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synthesis showed little effect upon quality of life,
service use or functioning, and mixed effects upon
remission. The evidence base for bibliotherapy
and life review was too limited to draw conclusions.
No treatments for anxiety were identiﬁed in this
population.
Similar effect sizes for PST on depressive symp-
toms have been noted in the general older adult
population (Jonsson et al., 2016; Kirkham et al.,
2016). However, Kirkham et al. (2016) also found
effects on disability.We included a greater number of
trials than Kirkham et al, and outcomes appeared
to be broadly consistent between different measures
used. It is, therefore, likely that either trials were
underpowered to detect differences (as functioning
was never a primary outcome), or the results were
mainly affected by a single study in which both study
arms also received case management (Alexopoulos
et al., 2016). The latter study may also be the reason
for the lack of effect on remission despite a strong
effect on symptoms or this may be due to the high
baseline depressive symptom scores (e.g. HAM-D
scores of 21–24). Heterogeneity was also very high
(≥90%) for some PSToutcomes, which could relate
to differences in timepoints (e.g. immediately post-
intervention or some weeks after) or intervention
components. There were too few studies reporting
quality of life outcomes to draw ﬁrm conclusions,
and quality of life appears to get little attention
in trials assessing late-life depression treatments
(Jonsson et al., 2016; Kirkham et al., 2016). While
a few larger studies have shown positive effects upon
late-life depression for primary care-based collabo-
rative care in the general older adult populations,
smaller studies in other settings indicate mixed ef-
fects (Dham et al., 2017) similarly to our review.
However, an individual patient meta-analysis has
reported similar collaborative care effects regardless
of the number or type of chronic physical conditions
across all ages (Panagioti et al., 2016).
Although executive dysfunction has been linked
to worse treatment outcomes (Tunvirachaisakul
et al., 2017), the two studies including participants
with a wider range of cognition scores (Kiosses
et al., 2010; 2015) found results consistent with
those restricted to normal scores, suggesting that
PST may be equally effective in a cognitively
impaired population. Mixed reporting of cognition
and mixed results in collaborative care studies
mean that conclusions cannot be drawn for these
interventions.
Strengths and limitations of the evidence base
The evidence base was largely at an unclear risk
of bias due to poor reporting. Studies at high risk
of bias were rare, apart from a few key collaborative
care trials. Regarding generalizability, the included
studies recruited ethnically and socioeconomically
diverse participants; however, most were carried
out in the US and all had a higher proportion of
female participants. Although within most studies
participants fell within a “normal” cognition range,
some studies included people with a range of cog-
nition levels that included those with cognitive
impairment. Within this review, PST appears to
have consistent effects on depression in studies
with participants who have greater cognitive im-
pairment (Kiosses et al., 2010; 2015) and those
with executive dysfunction but no physical disabil-
ity (Alexopoulos et al., 2003; Areán et al., 2010).
Post-intervention effectiveness was well-docu-
mented, but follow-up periods of over one year
were rare. Previous research suggests that depres-
sion is associated with faster physical decline and
greater health service use (Djernes et al., 2011;
Vaughan et al., 2015). Reducing depression may
maintain physical functioning, rather than improve
it, whichmay only be apparent in larger samples over
longer follow up. Quality of life information was
limited, while adverse event data were omitted by all
but two studies (Banerjee et al., 1996; Kiosses et al.,
2015). We found no trials of CBT or any therapies
for anxiety targeted to our population. Attrition in
many studies was similar across control and treat-
ment arms, suggesting that dropout was not an issue
likely to affect review results. However, collaborative
care studies had mixed ﬁdelity and adherence in
those measuring it, which may be a source of het-
erogeneity in outcomes (e.g. in Ell et al. [2007] 30%
received no intervention care). Within PST, gener-
ally high ﬁdelity scores were reported and where
assessed, participant attendance was fairly high,
even for studies with greater numbers of sessions.
Book-based CBT had very low adherence (on aver-
age only half of the book was read [Landreville and
Bissonnette, 1997]).
Strengths and limitations of the review
We searched a wide range of databases using com-
prehensive search terms, and additional methods
located only one extra subgroup analysis and one
small study. One reviewer assessed titles, abstracts,
and full texts. However, they took an inclusive
approach and a proportion were screened indepen-
dently by a second reviewer with good agreement.We
did not include trials of interventions for depression
in older people as a general population. Although
these may include some participants with difﬁculties
in functioning arising from physical comorbidities,
they are only likely to be a small proportion as the
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mean age within many of these trials is 65–70 (Gould
et al., 2012b; 2012a). However, we took an inclusive
approach to screening to identify larger trials that
included a subgroup analysis in a frailer population.
Two independent reviewers assessed risk of bias and
extracted meta-analysis data. Meta-analysis was lim-
ited by inconsistencies in outcome timepoints (e.g.
immediately post-intervention to six weeks after),
differing intervention lengths and poor study quality.
We received a good response from authors to our
requests for further data.
Implications for practice
Currently, UK psychological therapy services com-
monly focus primarily on delivering CBT for depres-
sion and anxiety, with low referral to and uptake of
these services in older people (Walters et al., 2018;
Wang et al., 2005). In our review, we found no
evidence regarding the use of CBT in older people
with physical comorbidities affecting functioning. It
may be thatCBT ismore cognitively demanding than
other therapies and so has not been trialed in those
who are frailer and more likely to have mild cognitive
impairment. Although there is some evidence for
its effectiveness in the general older adult popula-
tion, effect sizes are smaller than for younger people
(Gould et al., 2012a; 2012b). Also, frailer people may
ﬁnd CBT difﬁcult or even detrimental to apply when
their problems or negative thoughts may be realistic
and valid (Isaacowitz and Seligman, 2002).
Home-based problem-solving therapy, delivered
by non-mental health specialists, in perhaps as few as
six sessions, may be effective in this population with
moderate-severe depressive symptoms, at least short-
term and should be considered in practice. The effect
size is slightly higher for modiﬁed PST (1.79 [3.39,
0.20], converting theMD from Figure 3[a] to SMD)
than that reported for SSRIs in general older adult
populations (SMD 1.2 [0.3–2.1]) (Kok et al., 2012).
PST also has a high level of acceptability (Gellis
et al., 2007; 2008; Kiosses et al., 2010; 2015) and
may address the importance placed by older people
with complex problems upon feeling a sense of mas-
tery about solving issues and helping a combination
of issues that older people with complex problems
attribute depression to (Von Faber et al., 2016).
Provision of this alternative therapy in routine care
may support increasing the access to mental health
support for frail older people. The evidence for
collaborative care is more conﬂicting and insufﬁcient
to make recommendations. Bibliotherapy and ‘life
review’ (a therapy including the recall, evaluation and
integration of life experiences to achieve a positive
sense of self in the later stages of life) (Lan et al., 2017)
lacked sufﬁcient evidence to make recommendations
for this group.
Implications for research
PST showed positive short-term effects for reducing
depressive symptoms, although it did not show
effects upon other outcomes. Large scale RCTs,
therefore, need to be powered to assess the effects
of PSTupon a more comprehensive set of outcomes
more relevant to older people, particularly function-
ing (a key frailty outcome) (Ferrucci et al., 2004) and
quality of life (Lenze et al., 2016), especially in the
long term. Evaluation of hospitalizations, social care
use, and cost-effectiveness is also vital to assist
commissioning decisions, as home-based services
are potentially costly butmay deliver long-term cost-
savings in health or social care use. Other non-
pharmacological interventions for depression that
have shown to be effective in the general older adult
populations, such as CBT, behavioral activation,
and life review (Gould et al., 2012a; 2012b; Lan
et al., 2017; Orgeta et al., 2017), may also offer
promise, but could be optimized through working
with frail older people to understand how these
treatments could be better tailored to their needs
and abilities. Book-basedCBThad low adherence in
this population and exercise interventions do not
appear to be effective when people have a medical
comorbidity (Schuch et al., 2016), so these may be
less useful avenues for investigation. Research into
interventions for anxiety (and comorbid anxiety and
depression, which negatively impact upon late-life
depression treatment outcomes [Tunvirachaisakul
et al., 2017]) in this population is also needed, as
the evidence base for older adults tends to focus on
depression to the detriment of other psychiatric
disorders (Dham et al., 2017).
Conclusions
Home-based problem-solving therapy may signiﬁ-
cantly reduce depressive symptoms in older adults
with physical comorbidities affecting functioning in
the short term. The evidence for collaborative care
is mixed in this population, and effects on func-
tioning, quality of life, and service use are currently
unknown. Other therapies and therapies for anxiety
lack an evidence base in this population and require
further investigation.
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